Of mice and men: hybridoma and recombinant antibodies

Ehrlich, 1900, On immunity with special reference to cell life, Proc. R. Soc. London, 66, 424, 10.1098/rspl.1899.0121 Köhler, 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256, 495, 10.1038/256495a0 Goding, 1996 James, 1987, Human monoclonal antibody production. Current status and future prospects, J. Immunol. Methods, 100, 5, 10.1016/0022-1759(87)90170-0 Hahn, 1999, Creation of human tumour cells with defined genetic elements, Nature, 400, 464, 10.1038/22780 Kipriyanov, 1999, Generation of recombinant antibodies, Mol. Biotechnol., 12, 173, 10.1385/MB:12:2:173 Fishwild, 1996, High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice, Nat. Biotechnol., 14, 845, 10.1038/nbt0796-845 Mendez, 1997, Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice, Nat. Genet., 15, 146, 10.1038/ng0297-146 Green, 1999, Antibody engineering via genetic engineering of the mouse, J. Immunol. Methods, 231, 11, 10.1016/S0022-1759(99)00137-4 Tomizuka, 2000, Double trans-chromosomic mice, Proc. Natl. Acad. Sci. U. S. A., 97, 722, 10.1073/pnas.97.2.722 Lonberg, 1995, Human antibodies from transgenic mice, Int. Rev. Immunol., 13, 65, 10.3109/08830189509061738 Yang, 1999, Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy, Cancer Res., 59, 1236 Borrebaeck, 1999, Human monoclonal antibodies, Nat. Biotechnol., 17, 621, 10.1038/10798 Huston, 1988, Protein engineering of antibody binding sites, Proc. Natl. Acad. Sci. U. S. A., 85, 5879, 10.1073/pnas.85.16.5879 Glockshuber, 1990, A comparison of strategies to stabilize immunoglobulin Fv-fragments, Biochemistry, 29, 1362, 10.1021/bi00458a002 Zhu, 1997, Remodeling domain interfaces to enhance heterodimer formation, Protein Sci., 6, 781, 10.1002/pro.5560060404 Ward, 1989, Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli, Nature, 341, 544, 10.1038/341544a0 Hamers-Casterman, 1993, Naturally occurring antibodies devoid of light chains, Nature, 363, 446, 10.1038/363446a0 Adams, 1998, Improving the tumor specificity and retention of antibody-based molecules, In Vivo, 12, 11 Holliger, 1993, ‘Diabodies’, Proc. Natl. Acad. Sci. U. S. A., 90, 6444, 10.1073/pnas.90.14.6444 Kortt, 1997, Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer, Protein Eng., 10, 423, 10.1093/protein/10.4.423 Le Gall, 1999, Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19, FEBS Lett., 453, 164, 10.1016/S0014-5793(99)00713-9 Kipriyanov, 1999, Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics, J. Mol. Biol., 293, 41, 10.1006/jmbi.1999.3156 Adams, 1993, Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv, Cancer Res., 53, 4026 Gruber, 1994, Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli, J. Immunol., 152, 5368, 10.4049/jimmunol.152.11.5368 Pack, 1992, Miniantibodies, Biochemistry, 31, 1579, 10.1021/bi00121a001 Hu, 1996, Minibody, Cancer Res., 56, 3055 Rheinnecker, 1996, Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen, J. Immunol., 157, 2989, 10.4049/jimmunol.157.7.2989 Kipriyanov, 1996, Affinity enhancement of a recombinant antibody, Protein Eng., 9, 203, 10.1093/protein/9.2.203 Falkenberg, 1995, In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter, J. Immunol. Methods, 179, 13, 10.1016/0022-1759(94)00266-Y Lowrey, 1994, A comparison of monoclonal antibody productivity in different hollow fiber bioreactors, J. Biotechnol., 36, 35, 10.1016/0168-1656(94)90020-5 Geisse, 1999, Protein expression in mammalian and insect cell systems, Methods Enzymol., 306, 19, 10.1016/S0076-6879(99)06004-8 Bebbington, 1992, High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker, BioTechnology, 10, 169, 10.1038/nbt0292-169 Pollock, 1999, Transgenic milk as a method for the production of recombinant antibodies, J. Immunol. Methods, 231, 147, 10.1016/S0022-1759(99)00151-9 Baguisi, 1999, Production of goats by somatic cell nuclear transfer, Nat. Biotechnol., 17, 456, 10.1038/8632 Hiatt, 1989, Production of antibodies in transgenic plants, Nature, 342, 76, 10.1038/342076a0 Ma, 1995, Generation and assembly of secretory antibodies in plants, Science, 268, 716, 10.1126/science.7732380 Conrad, 1998, Compartment-specific accumulation of recombinant immunoglobulins in plant cells, Plant Mol. Biol., 38, 101, 10.1023/A:1006029617949 Fischer, 1999, Towards molecular farming in the future, Biotechnol. Appl. Biochem., 30, 113, 10.1111/j.1470-8744.1999.tb00900.x Skerra, 1988, Assembly of a functional immunoglobulin Fv fragment in Escherichia coli, Science, 240, 1038, 10.1126/science.3285470 Knappik, 1993, The effect of folding catalysts on the in vivo folding process of different antibody fragments expressed in Escherichia coli, BioTechnology, 11, 77, 10.1038/nbt0193-77 Bothmann, 1998, Selection for a periplasmic factor improving phage display and functional periplasmic expression, Nat. Biotechnol., 16, 376, 10.1038/nbt0498-376 Kipriyanov, 1997, High level production of soluble single chain antibodies in small-scale Escherichia coli cultures, J. Immunol. Methods, 200, 69, 10.1016/S0022-1759(96)00188-3 Horn, 1996, High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions, Appl. Microbiol. Biotechnol., 46, 524, 10.1007/s002530050855